FDA head explains decision to drop ‘black box’ warnings from menopause hormone treatment
Summary
The FDA plans to ask drug companies to take off "black box" warnings from menopause hormone treatment labels. These warnings might have stopped many women from using these helpful medications.Key Facts
- The FDA wants to remove "black box" warnings on menopause hormone treatments.
- "Black box" warnings are prominent labels indicating serious risks.
- The FDA believes these warnings have discouraged women from using the medication.
- The decision aims to help women access treatments for menopause symptoms.
- Dr. Marty Makary, FDA Commissioner, explained the decision in detail.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.